AMSTERDAM (Thomson Financial) - Royal Philips NV said it is extending the
period of its tender offer for Respironics Inc until March 6, as it also
announced that 82 pct of Respironics' outstanding shares have been tendered to
its offer.
Philips said the tender period is being extended because regulatory approval
from the European Commission has not yet been obtained.
The Commission' inquiry deadline is set for March 5.
Philips said in December it has agreed to buy Respironics for 66 usd per
share in cash, valuing Respironics at about 5.1 bln usd.
Aaron Gray-Block; aaron.gray-block@thomson.com
agb/rfw
COPYRIGHT
Copyright Thomson Financial News Limited 2007. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content,
including by framing or similar means, is expressly prohibited without the prior
written consent of Thomson Financial News.
|